Research and Development

The global pharmaceutical market is set to return to stronger growth of 5-7% by 2016, according to a new forecast. …

GlaxoSmithKline and US biopharma firm Theravance have submitted their investigational chronic obstructive pulmonary disease (COPD) drug to regulators in Europe …

AstraZeneca and Dr Steven Paul of Weill Cornell Medical College have unveiled a new research alliance that brings four leading …

AstraZeneca is to acquire a portfolio of neuroscience assets from Link Medicine, a private US pharma firm.The deal is the …

Takeda Pharmaceuticals has appointed Rob Gallo as head of Corporate Communications, Europe and Canada. Since 2010 Gallo has been the …

The first round of appointments to commissioning support service (CSS) managing director posts has been made by the NHS Commissioning …

Swiss speciality pharmaceutical company Actelion has unveiled a new cost saving plan which could include the loss of 260 jobs …

Belgium-based Amakem NV has announced the appointment of Maarten van Geffen as head of CMC and Operations. The kinase platform …

Janssen has licensed a portfolio of drugs designed to regenerate insulin-producing beta cells. Janssen will receive exclusive access to a …

Swedish biotech company BioInvent has suffered a new blow with the failure of its lead pipeline candidate.  The company’s share …

Biopharma development firm Chelsea Therapeutics has announced a major corporate reorganisation. The move includes a significant reduction in headcount, the …

Jan Van Ruymbeke has been appointed as the new chief executive of Daiichi Sankyo Europe from October. Van Ruymbeke, from Belgium, …

Eli Lilly officially opened its new research facilities at its R&D base in Erl Wood in Surrey in April. The …

Xarelto is to be given a FDA fast-track review for a range of anti-blood clotting uses. Xarelto (rivaroxaban) gained its …

Savient Pharmaceuticals has appointed Louis Ferrari to the role of president and chief executive for the firm. Ferrari succeeds Savient’s …